SCHEMBL9786893

SCHEMBL9786893

O=C(Oc1ccc([N+](=O)[O-])cc1)c1ccc(O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.74
PKM P14618 1/20 0.74
HGFAC Q04756 1/20 0.65
NR1H4 Q96RI1 1/20 0.60
MAPT P10636 4/20 0.58
ALDH1A1 P00352 2/20 0.58
GAA P10253 2/20 0.56
HPGD P15428 1/20 0.56
ALOX5 P09917 1/20 0.54
HTT P42858 1/20 0.52
RAB9A P51151 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
CES1 P23141 1/20 0.52
XDH P47989 1/20 0.51
BCL9 O00512 1/20 0.50
CTNNB1 P35222 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
SRD5A2 P31213 1/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9135711 1.00 KMT2A (0.74) KMT2APKMHGFACNR1H4MAPT
SCHEMBL18434657 0.93 KMT2A (0.84) KMT2APKMHGFACNR1H4MAPT
SCHEMBL4951809 0.93 KMT2A (0.84) KMT2APKMHGFACNR1H4MAPT
SCHEMBL542043 0.93 KMT2A (0.84) KMT2APKMHGFACNR1H4MAPT
SCHEMBL10636579 0.93 KMT2A (0.84) KMT2APKMHGFACNR1H4MAPT
P-Nitrophenol SCHEMBL7158777 0.92 KMT2A (0.64) KMT2APKMHGFACNR1H4MAPT
SCHEMBL27462144 0.91 HGFAC (0.67) KMT2APKMHGFACNR1H4MAPT
SCHEMBL16375430 0.88 KMT2A (0.77) KMT2APKMHGFACNR1H4MAPT
SCHEMBL3145157 0.88 KMT2A (0.77) KMT2APKMHGFACNR1H4MAPT
SCHEMBL12489991 0.88 PKM (0.77) KMT2APKMHGFACNR1H4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240019746-A1 ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2024-01-18 US disclosed
US-20240019746-A1 ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2024-01-18 US disclosed
CN-112322306-B Ultrahigh-polarity chiral liquid crystal material, liquid crystal laser and preparation method thereof 华南理工大学 2022-05-24 CN disclosed
WO-2022089501-A1 ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR 华南理工大学 2022-05-05 WO disclosed
CN-112375168-B Side chain rod-shaped polar liquid crystal polymer, preparation method thereof and application thereof in nonlinear optical field 华南理工大学 2022-03-29 CN disclosed
CN-112375168-A Side chain rod-shaped polar liquid crystal polymer, preparation method thereof and application thereof in nonlinear optical field 华南理工大学 2021-02-19 CN disclosed
CN-112342032-A Rod-like polar liquid crystal molecule, preparation method thereof and rod-like polar nematic liquid crystal 华南理工大学 2021-02-09 CN disclosed
CN-112322306-A Ultrahigh-polarity chiral liquid crystal material, liquid crystal laser and preparation method thereof 华南理工大学 2021-02-05 CN disclosed
US-10175573-B2 Curable composition and color filter FUJIFILM CORPORATION (JP) 2019-01-08 US disclosed
US-20150316844-A1 CURABLE COMPOSITION AND COLOR FILTER FUJIFILM CORPORATION (JP) 2015-11-05 US disclosed
US-20080207913-A1 Poly(ethylene glycol) containing chemically disparate endgroups INTEZYNE TECHNOLOGIES (US) 2008-08-28 US disclosed
US-20080207913-A1 Poly(ethylene glycol) containing chemically disparate endgroups INTEZYNE TECHNOLOGIES (US) 2008-08-28 US disclosed
US-20080188638-A1 Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof INTEZYNE TECHNOLOGIES (US) 2008-08-07 US disclosed
US-20080188638-A1 Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof INTEZYNE TECHNOLOGIES (US) 2008-08-07 US disclosed
WO-2007127440-A2 HETEROFUNCTIONAL POLY(ETHYLENE GLYCOL) CONTAINING ACID-LABILE AMINO PROTECTING GROUPS AND USES THEREOF INTEZYNE TECHNOLOGIES, INC. (US) 2007-11-08 WO disclosed
WO-2007127473-A2 POLY (ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS INTEZYNE TECHNOLOGIES, INC. (US) 2007-11-08 WO disclosed
US-20070106035-A1 Aromatic di-acid-containing poly (ester amide) polymers and methods of use MEDIVAS, LLC (US) 2007-05-10 US disclosed
WO-2007050583-A2 AROMATIC DI-ACID-CONTAINING POLY (ESTER AMIDE) POLYMERS AND METHODS OF USE MEDIVAS, LLC (US) 2007-05-03 WO disclosed
US-5043403-A Polycarbonates containing mesogenic compounds as end groups, their preparation and their use BAYER AKTIENGESELLSCHAFT (DE) 1991-08-27 US disclosed
EP-0347682-A2 Polycarbonates with mesogenic compounds as end groups, their preparation and their use BAYER AG (DE) 1989-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188638-A1 Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof LNPEP, GNE, DNPEP KMT2A 2775/4885PKM 2903/4885HGFAC 288/4885
US-20080207913-A1 Poly(ethylene glycol) containing chemically disparate endgroups GNE, EPRS1, ALG1 KMT2A 3924/4885PKM 3080/4885HGFAC 1423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.